Hyperfine (HYPR) FCF Margin Growth (1y) (2022 - 2026)
Hyperfine (HYPR) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -473.00 |
| 10 | Hyperfine | 90.12 Mn | 45.35 Mn | 1.98 Mn | 12,438.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,438.00 |
| Mar 31, 2026 | 19,425.00 |
| Dec 31, 2025 | 22,189.00 |
| Sep 30, 2025 | 6,310.00 |
| Jun 30, 2025 | -7,672.00 |
| Mar 31, 2025 | -2,463.00 |
| Dec 31, 2024 | 6,201.00 |
| Sep 30, 2024 | 13,771.00 |
| Jun 30, 2024 | 2,723.00 |
| Mar 31, 2024 | 11,117.00 |
| Dec 31, 2023 | 70,852.00 |
| Sep 30, 2023 | 19,829.00 |
| Jun 30, 2023 | 81,025.00 |
| Mar 31, 2023 | 129,917.00 |
| Dec 31, 2022 | 320,204.00 |
| Sep 30, 2022 | 227,487.00 |
| Jun 30, 2022 | 213,894.00 |
| Mar 31, 2022 | 46,663.00 |